Panel Discussion: Is 2026 the Year for Demonstrating the Practical ROI of AI/ML-Integrated Discovery for Small Molecules?
8:30 am - Thursday 19th March 2026
This industry leaders panel will discuss the small molecule industry collaborations and advancements shaping the space, key challenges to overcome, and where the biggest opportunities remain.
- Taking stock of the strengths, weaknesses, opportunities and threats (SWOT) of AI/ML-derived small molecules
- What advancements in AI/ML x med chem x computational convergence should we be most excited about?
- How do you perceive the AI/ML-derived small molecule space? How has industry sentiment changed in the last 12 months?
- What are the technical or scientific bottlenecks that are slowing AI/ML-derived small molecule discovery?
- What are the most reliable and experimentally validated use cases for AI/ML-methods that are being integrated into the small molecule discovery funnel? And which use cases for small molecule discovery remain challenging to get right?
Speakers:
Co-Founder, Chief Technology Officer & Senior Principal
Montai Therapeutics & Flagship Pioneering
